Actively Recruiting
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
Led by Zenchi, Inc. · Updated on 2025-09-12
42
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
Sponsors
Z
Zenchi, Inc.
Lead Sponsor
C
Citruslabs
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a 24-week, single-arm, open-label, virtual study evaluating the effects of Elix Cycle Balance and Elix Daily Harmony on uterine fibroid-related symptoms and quality of life in 42 participants. Participants will self-administer the investigational herbal supplements daily and complete validated questionnaires at scheduled timepoints to assess symptom severity and quality of life.
CONDITIONS
Official Title
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be female.
- Be aged 20-45.
- Have a BMI between 18.5 and 24.9 kg/m2.
- Have a self-reported prior diagnosis of uterine fibroids.
- Be generally healthy without uncontrolled chronic diseases.
- Experience moderate to severe menstrual discomfort related to pelvic cramps, bloating, mood swings, or fatigue.
- Have experienced menstrual cramps during cycles for at least six months.
- If using hormonal birth control, have been using it consistently for at least three months and still have menstrual periods.
- If using other oral over-the-counter supplements or herbal remedies, have been taking them consistently for at least three months and are willing to maintain this during the study.
- Willing to avoid introducing new products, medications, supplements, or lifestyle changes affecting the menstrual cycle during the study.
- Willing to avoid any new vaccines during the 6-month study period.
- Follow a stable exercise routine and agree not to change the amount of exercise during the study.
- Agree not to change other interventions like massage, chiropractic medicine, or acupuncture during the study.
- Reside in the United States.
You will not qualify if you...
- Do not have a regular menstrual cycle (21-35 days).
- Do not experience menstrual cramping.
- Follow extreme diets such as dry fasts, water fasts, or ketogenic diets.
- Have experienced significant weight loss in the past three months.
- Are unwilling to stop medications or supplements that affect the menstrual cycle.
- Have pre-existing chronic conditions that prevent following the study protocol, including oncological or psychiatric disorders.
- Have severe allergic reactions or allergies to study product ingredients.
- Are pregnant, breastfeeding, or trying to conceive during the study.
- Are unwilling to follow the study protocol.
- Have stopped, started, or changed hormonal birth control in the past three months.
- Have previously used Elix Cycle Balance.
- Are current smokers or have smoked in the past three months.
- Have diagnoses of PCOS, Endometriosis, PMDD, Adenomyosis, Hashimoto's thyroiditis, Grave's disease, other thyroid disorders, hyperprolactinemia, Cushing's disease, congenital adrenal hyperplasia, anorexia, bulimia, orthorexia, binge eating, or other eating disorders.
- Have a history of endocrine disorders such as thyroid disorders or diabetes.
- Have a history of hypertension, hyperlipidemia, or venous embolism.
- Have a BMI greater than 25 kg/m2.
- Have other causes of chronic pelvic pain including infectious diseases, gastrointestinal, psychological disorders, fibromyalgia, or chronic fatigue syndrome.
- Have had gynecological surgery or treatment in the last 6 months.
- Have a history of abnormal pap smear, gynecological cancer, or uterine malformations.
- Have chronic urinary tract infections or diagnosed gastrointestinal conditions like IBS, IBD, Crohn's disease, or ulcerative colitis.
- Are currently or will be participating in another research study during this study period.
- Consume more than 5 alcoholic drinks per week.
- Have had a vaccine in the last 3 months.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Citruslabs
Las Vegas, Nevada, United States, 89118
Actively Recruiting
Research Team
P
Patrick Renner, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here